Kexing Biopharm Co., Ltd. (SHA:688136)
China · Delayed Price · Currency is CNY 46.81
+0.33 (0.71%)
Aug 8, 2025, 2:45 PM CST
Kexing Biopharm Market Cap
Kexing Biopharm has a market cap or net worth of 9.32 billion as of August 8, 2025. Its market cap has increased by 186.55% in one year.
Market Cap
9.32B
Enterprise Value
10.00B
Revenue
1.40B
Ranking
n/a
PE Ratio
205.97
Stock Price
46.81
Market Cap Chart
Since December 14, 2020, Kexing Biopharm's market cap has increased from 8.15B to 9.32B, an increase of 14.34%. That is a compound annual growth rate of 2.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 9.27B | 114.36% |
| Dec 31, 2024 | 4.32B | 7.17% |
| Dec 29, 2023 | 4.03B | -5.31% |
| Dec 30, 2022 | 4.26B | -24.16% |
| Dec 31, 2021 | 5.62B | -30.78% |
| Dec 31, 2020 | 8.11B | -0.41% |
| Dec 14, 2020 | 8.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 411.71B |
| Shenzhen Mindray Bio-Medical Electronics | 275.78B |
| WuXi AppTec | 265.90B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.61B |
| Aier Eye Hospital Group | 119.54B |
| Sichuan Biokin Pharmaceutical | 119.08B |
| Shanghai United Imaging Healthcare | 105.41B |
| Yunnan Baiyao Group Co.,Ltd | 100.24B |